Publish the monthly exercise status for the 13th stock acquisition rights (with exercise price adjustment clause) issued on July 31, 2025, for July 2026. Granted shares: 76,000 shares; exercised stock acquisition rights: 760 units; exercise ratio: 0.17%; unexercised: 9,098 shares \u2192 8,338 shares decrease. At the end of the previous month, issued shares were 57,483,412 (including 11,387 treasury shares).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4576","jir_company_name":"De WESTERN Therapitecs Institute","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4576-20260803-01.pdf","jir_short_summary":"Publish the monthly exercise status for the 13th stock acquisition rights (with exercise price adjustment clause) issued on July 31, 2025, for July 2026. Granted shares: 76,000 shares; exercised stock acquisition rights: 760 units; exercise ratio: 0.17%; unexercised: 9,098 shares \u2192 8,338 shares decrease. At the end of the previous month, issued shares were 57,483,412 (including 11,387 treasury shares).","jir_summary":"### \u6708\u9593\u884c\u4f7f\u72b6\u6cc1\u306e\u6982\u8981\nThis report conveys the monthly exercise status for the 13th stock acquisition rights with an exercise price adjustment clause issued on July 31, 2025, for July 2026. For the target month, the number of granted shares is 76,000, the number of stock acquisition rights exercised is 760, and the exercise ratio against the issued total is 0.17%, remaining at a low level. Unexercised stock acquisition rights at month-end total 8,338 shares, down from 9,098 shares at the end of the previous month.\n\n### Share issuance status and compliance\nThe number of issued shares is 57,483,412 (including 11,387 treasury shares), and compliance with exercise restrictions is properly managed. The exercise this time was conducted in accordance with specific internal period conditions and is reported to conform to exchange and market rules.","jir_financial_highlights":"Number of issued shares: 76,000 shares (vs prior month same as above)\nNumber of exercised stock acquisition rights: 760 shares (YoY Unknown)\nExercise ratio: 0.17% (Unknown)\nNumber of unexercised stock acquisition rights (end of prior month): 9,098 shares (vs prior month-end decrease)\nNumber of unexercised stock acquisition rights (end of this month): 8,338 shares (this month-end decrease)","jir_category":"","jir_hashtags":"#De Western Therapitecs Institute, #StockOption, #IR","jir_key_figures":"Number of issued shares: 76,000 shares\nNumber of stock acquisition rights exercised: 760 units\nExercise ratio: 0.17%","jir_meta_title":"\u3010De Western Therapitecs Institute\u3011 Monthly stock option exercise status disclosed \uff5c July 2026","jir_meta_description":"Disclosure of the July monthly exercise status for the 13th stock acquisition rights (with exercise price adjustment clause). Granted shares: 76,000; exercised: 760; exercise ratio: 0.17%; unexercised: 8,338 shares remaining. Issued shares: 57,483,412 (treasury shares: 11,387).","jir_og_title":"De Western Therapitecs Institute | Monthly Stock Option Exercise Status July 2026","jir_og_description":"Announcement of the July monthly exercise status for stock acquisition rights. Granted shares: 76,000; exercised: 760; exercise ratio: 0.17%; unexercised: 8,338 shares.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59943,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-92445","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n